NASDAQ:BIMI

BOQI International Medical Competitors

$1.38
+0.03 (+2.22 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.34
$1.43
50-Day Range
$1.35
$1.87
52-Week Range
$1.32
$4.09
Volume331,406 shs
Average Volume1.12 million shs
Market Capitalization$27.78 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.07

Competitors

BOQI International Medical (NASDAQ:BIMI) Vs. PH, CR, WTS, B, HLIO, and MWA

Should you be buying BIMI stock or one of its competitors? Companies in the industry of "miscellaneous fabricated metal products" are considered alternatives and competitors to BOQI International Medical, including Parker-Hannifin (PH), Crane (CR), Watts Water Technologies (WTS), Barnes Group (B), Helios Technologies (HLIO), and Mueller Water Products (MWA).

Parker-Hannifin (NYSE:PH) and BOQI International Medical (NASDAQ:BIMI) are both industrial products companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Earnings & Valuation

This table compares Parker-Hannifin and BOQI International Medical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Parker-Hannifin$13.70 billion3.01$1.21 billion$10.7929.59
BOQI International Medical$160,000.00173.63$-4,440,000.00N/AN/A

Parker-Hannifin has higher revenue and earnings than BOQI International Medical.

Profitability

This table compares Parker-Hannifin and BOQI International Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Parker-Hannifin8.75%22.77%7.13%
BOQI International MedicalN/A1.73%0.54%

Analyst Recommendations

This is a breakdown of current ratings and price targets for Parker-Hannifin and BOQI International Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Parker-Hannifin011202.92
BOQI International Medical0000N/A

Parker-Hannifin currently has a consensus price target of $323.6154, suggesting a potential upside of 1.36%. Given Parker-Hannifin's higher probable upside, equities analysts clearly believe Parker-Hannifin is more favorable than BOQI International Medical.

Institutional & Insider Ownership

77.4% of Parker-Hannifin shares are held by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are held by institutional investors. 1.5% of Parker-Hannifin shares are held by insiders. Comparatively, 29.6% of BOQI International Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Parker-Hannifin has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Summary

Parker-Hannifin beats BOQI International Medical on 9 of the 11 factors compared between the two stocks.

Crane (NYSE:CR) and BOQI International Medical (NASDAQ:BIMI) are both multi-sector conglomerates companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Earnings & Valuation

This table compares Crane and BOQI International Medical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crane$3.28 billion1.76$133.30 million$6.0216.48
BOQI International Medical$160,000.00173.63$-4,440,000.00N/AN/A

Crane has higher revenue and earnings than BOQI International Medical.

Profitability

This table compares Crane and BOQI International Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Crane0.71%18.09%5.80%
BOQI International MedicalN/A1.73%0.54%

Volatility and Risk

Crane has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Crane and BOQI International Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Crane01302.75
BOQI International Medical0000N/A

Crane currently has a consensus price target of $92.6667, suggesting a potential downside of 6.59%. Given Crane's higher probable upside, equities analysts clearly believe Crane is more favorable than BOQI International Medical.

Institutional & Insider Ownership

65.9% of Crane shares are held by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are held by institutional investors. 3.6% of Crane shares are held by insiders. Comparatively, 29.6% of BOQI International Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Crane beats BOQI International Medical on 9 of the 11 factors compared between the two stocks.

Watts Water Technologies (NYSE:WTS) and BOQI International Medical (NASDAQ:BIMI) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Earnings and Valuation

This table compares Watts Water Technologies and BOQI International Medical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Watts Water Technologies$1.60 billion2.86$131.50 million$4.0733.50
BOQI International Medical$160,000.00173.63$-4,440,000.00N/AN/A

Watts Water Technologies has higher revenue and earnings than BOQI International Medical.

Profitability

This table compares Watts Water Technologies and BOQI International Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Watts Water Technologies7.67%13.15%7.45%
BOQI International MedicalN/A1.73%0.54%

Risk & Volatility

Watts Water Technologies has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Watts Water Technologies and BOQI International Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Watts Water Technologies03002.00
BOQI International Medical0000N/A

Watts Water Technologies currently has a consensus price target of $124.00, suggesting a potential downside of 9.05%. Given Watts Water Technologies' higher probable upside, equities research analysts plainly believe Watts Water Technologies is more favorable than BOQI International Medical.

Institutional and Insider Ownership

75.0% of Watts Water Technologies shares are owned by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are owned by institutional investors. 1.1% of Watts Water Technologies shares are owned by insiders. Comparatively, 29.6% of BOQI International Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Watts Water Technologies beats BOQI International Medical on 8 of the 10 factors compared between the two stocks.

Barnes Group (NYSE:B) and BOQI International Medical (NASDAQ:BIMI) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Earnings and Valuation

This table compares Barnes Group and BOQI International Medical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Barnes Group$1.49 billion1.82$158.35 million$3.2116.72
BOQI International Medical$160,000.00173.63$-4,440,000.00N/AN/A

Barnes Group has higher revenue and earnings than BOQI International Medical.

Profitability

This table compares Barnes Group and BOQI International Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Barnes Group7.19%8.63%4.14%
BOQI International MedicalN/A1.73%0.54%

Risk & Volatility

Barnes Group has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Barnes Group and BOQI International Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Barnes Group35201.90
BOQI International Medical0000N/A

Barnes Group currently has a consensus price target of $42.20, suggesting a potential downside of 21.39%. Given Barnes Group's higher probable upside, equities research analysts plainly believe Barnes Group is more favorable than BOQI International Medical.

Institutional and Insider Ownership

86.0% of Barnes Group shares are owned by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are owned by institutional investors. 8.4% of Barnes Group shares are owned by insiders. Comparatively, 29.6% of BOQI International Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Barnes Group beats BOQI International Medical on 9 of the 11 factors compared between the two stocks.

Helios Technologies (NASDAQ:HLIO) and BOQI International Medical (NASDAQ:BIMI) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Earnings and Valuation

This table compares Helios Technologies and BOQI International Medical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helios Technologies$554.66 million4.41$60.27 million$2.4331.26
BOQI International Medical$160,000.00173.63$-4,440,000.00N/AN/A

Helios Technologies has higher revenue and earnings than BOQI International Medical.

Profitability

This table compares Helios Technologies and BOQI International Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Helios Technologies4.52%12.24%6.96%
BOQI International MedicalN/A1.73%0.54%

Risk & Volatility

Helios Technologies has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Helios Technologies and BOQI International Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Helios Technologies01102.50
BOQI International Medical0000N/A

Helios Technologies currently has a consensus price target of $79.00, suggesting a potential upside of 4.02%. Given Helios Technologies' higher probable upside, equities research analysts plainly believe Helios Technologies is more favorable than BOQI International Medical.

Institutional and Insider Ownership

87.3% of Helios Technologies shares are owned by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are owned by institutional investors. 4.1% of Helios Technologies shares are owned by insiders. Comparatively, 29.6% of BOQI International Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Helios Technologies beats BOQI International Medical on 9 of the 11 factors compared between the two stocks.

Mueller Water Products (NYSE:MWA) and BOQI International Medical (NASDAQ:BIMI) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Institutional and Insider Ownership

84.6% of Mueller Water Products shares are owned by institutional investors. Comparatively, 0.9% of BOQI International Medical shares are owned by institutional investors. 1.5% of Mueller Water Products shares are owned by insiders. Comparatively, 29.6% of BOQI International Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Mueller Water Products and BOQI International Medical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mueller Water Products$964.10 million2.45$72 million$0.5228.62
BOQI International Medical$160,000.00173.63$-4,440,000.00N/AN/A

Mueller Water Products has higher revenue and earnings than BOQI International Medical.

Risk & Volatility

Mueller Water Products has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, BOQI International Medical has a beta of -0.07, suggesting that its share price is 107% less volatile than the S&P 500.

Profitability

This table compares Mueller Water Products and BOQI International Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mueller Water Products7.47%13.39%6.11%
BOQI International MedicalN/A1.73%0.54%

Analyst Ratings

This is a summary of current ratings and recommmendations for Mueller Water Products and BOQI International Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mueller Water Products01302.75
BOQI International Medical0000N/A

Mueller Water Products currently has a consensus price target of $13.00, suggesting a potential downside of 12.63%. Given Mueller Water Products' higher probable upside, equities research analysts plainly believe Mueller Water Products is more favorable than BOQI International Medical.

Summary

Mueller Water Products beats BOQI International Medical on 9 of the 11 factors compared between the two stocks.


BOQI International Medical Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Parker-Hannifin logo
PH
Parker-Hannifin
2.1$319.26+1.0%$41.21 billion$13.70 billion34.93Analyst Report
Insider Selling
Decrease in Short Interest
Analyst Revision
Crane logo
CR
Crane
1.9$99.20+0.5%$5.77 billion$3.28 billion261.06Earnings Announcement
Dividend Announcement
Analyst Report
Analyst Revision
Watts Water Technologies logo
WTS
Watts Water Technologies
1.7$136.34+1.5%$4.58 billion$1.60 billion40.10Earnings Announcement
Dividend Increase
High Trading Volume
Analyst Revision
News Coverage
Barnes Group logo
B
Barnes Group
1.8$53.68+0.9%$2.72 billion$1.49 billion31.76Analyst Revision
Helios Technologies logo
HLIO
Helios Technologies
1.6$75.95+1.7%$2.45 billion$554.66 million110.07Upcoming Earnings
Analyst Downgrade
Mueller Water Products logo
MWA
Mueller Water Products
2.0$14.88+0.3%$2.36 billion$964.10 million33.07Earnings Announcement
Analyst Revision
News Coverage
CIRCOR International logo
CIR
CIRCOR International
1.5$37.35+1.3%$753.35 million$964.31 million-4.40Upcoming Earnings
NISN
Nisun International Enterprise Development Group
0.0$13.75+8.4%$261.14 million$21.10 million0.00
ZK International Group logo
ZKIN
ZK International Group
0.5$5.45+4.0%$116.20 million$63.88 million0.00Upcoming Earnings
HIHO
Highway
0.9$3.34+4.5%$13.27 million$12.56 million15.18Gap Up
This page was last updated on 5/7/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.